Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Thrombosis Research
|
May 15, 1992
Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT)
C Seeber, E Hiller, E Holler, et al.
Zentralblatt Fur Gynakologie
|
January 1, 1975
[Immunologic studies in relation to cryotherapy of gynecologic diseases]
K Renziehausen, M Schröder, C Seeber, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1972
Screening, fermentation, isolation, and chracterization of trypanomycin, a new antibiotic
W Fleck, D Strauss, C Schönfeld, et al.
Neuroscience Letters
|
May 16, 1997
Alpha1 antichymotrypsin signal peptide polymorphism in sporadic Creutzfeldt-Jakob disease
M Salvatore, A C Seeber, B Nacmias, et al.
Journal of the Neurological Sciences
|
December 1, 1996
AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987-93) and differential incidence according to mode of transmission of HIV-1 infection
A Chiesi, A C Seeber, L G Dally, et al.
Neuroscience Letters
|
October 20, 1995
Apolipoprotein E in sporadic and familial Creutzfeldt-Jakob disease
M Salvatore, A C Seeber, B Nacmias, et al.
Bone Marrow Transplantation
|
August 1, 1991
Treatment of aGVHD with OKT3: clinical outcome and side-effects associated with release of TNF alpha
B Gleixner, H J Kolb, E Holler, et al.
Blood
|
May 15, 1989
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation
E Holler, H J Kolb, E Hiller, et al.
AIDS (London, England)
|
April 16, 1998
Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol Team
O Pontesilli, E C Guerra, A Ammassari, et al.
The Journal of Infectious Diseases
|
February 1, 1997
A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infection
M Floridia, S Vella, A C Seeber, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Thrombosis Research
|
May 15, 1992
Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT)
C Seeber, E Hiller, E Holler, et al.
Zentralblatt Fur Gynakologie
|
January 1, 1975
[Immunologic studies in relation to cryotherapy of gynecologic diseases]
K Renziehausen, M Schröder, C Seeber, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1972
Screening, fermentation, isolation, and chracterization of trypanomycin, a new antibiotic
W Fleck, D Strauss, C Schönfeld, et al.
Neuroscience Letters
|
May 16, 1997
Alpha1 antichymotrypsin signal peptide polymorphism in sporadic Creutzfeldt-Jakob disease
M Salvatore, A C Seeber, B Nacmias, et al.
Journal of the Neurological Sciences
|
December 1, 1996
AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987-93) and differential incidence according to mode of transmission of HIV-1 infection
A Chiesi, A C Seeber, L G Dally, et al.
Neuroscience Letters
|
October 20, 1995
Apolipoprotein E in sporadic and familial Creutzfeldt-Jakob disease
M Salvatore, A C Seeber, B Nacmias, et al.
Bone Marrow Transplantation
|
August 1, 1991
Treatment of aGVHD with OKT3: clinical outcome and side-effects associated with release of TNF alpha
B Gleixner, H J Kolb, E Holler, et al.
Blood
|
May 15, 1989
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation
E Holler, H J Kolb, E Hiller, et al.
AIDS (London, England)
|
April 16, 1998
Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol Team
O Pontesilli, E C Guerra, A Ammassari, et al.
The Journal of Infectious Diseases
|
February 1, 1997
A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infection
M Floridia, S Vella, A C Seeber, et al.
Page
of 2